pharmaphorum

AUGUST 4, 2020

New research looks at the factors that speed up and slow down HTA appraisals for rare disease medicines across Europe. Rare diseases drugs have always faced challenges when it comes to HTA approvals, even as governments bring in more regulatory policies that make their path through assessment easier. Several factors make it difficult for HTA bodies often to assess orphan drugs, including a lack of robust trial data due to difficulties in finding patients, the absence of randomised controlled tri

Labelling 122

Labelling 122

Outsourcing Pharma

AUGUST 5, 2020

The firms are working to create a platform that gives the ability to monitor temperature-sensitive treatments, vaccines and other products.

Vaccines 119

Vaccines 119

Druggist

AUGUST 3, 2020

Otrivine Extra Dual Relief is a pharmacy only medication and the only over the counter product containing ipratropium bromide for the management of congestion and runny nose caused by colds. This post summarises the essential information about Otrivine Extra Dual Relief nasal spray. 1. Otrivine Extra Dual Relief indicated use Otrivine Extra spray is used for the management of congestion and rhinorrhoea caused by colds. 2.

98

98

Pharma Marketing Network

AUGUST 3, 2020

Recently, the Healthcare Businesswomen’s Association (HBA) held a webinar entitled, Virtual Best Practices: Clarity, Collaboration and Connecting , which dove into the topic of “Zoom fatigue,” a new, commonly used term defined by the draining feeling you experience after a day of long, unnecessary meetings. We are all facing new challenges in the rapidly changing work environment.

Communication 94

Communication 94

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patient Care

pharmaphorum

AUGUST 7, 2020

Pfizer has signed a multi-year agreement with Gilead to manufacture and supply the COVID-19 antiviral remdesivir, which is also being tested in combination with other drugs in an effort to fight the pandemic. Under the terms of the agreement Pfizer will become one of several external partners who manufacture the investigational treatment for the disease.

Immunization 119

Immunization FDA 119

Outsourcing Pharma

AUGUST 5, 2020

The bipartisan bill calls for an assessment of the countryâs pharma supply chain, including potential vulnerabilities and impact of foreign manufacturing.

98

98

Pharma Tutor

AUGUST 5, 2020

52

52

pharmaphorum

AUGUST 5, 2020

The UK government has asked pharma companies to build a six-week stockpile of drugs and find alternative shipping routes to the congested Dover-Calais crossing as the country heads for Brexit at the end of the year. In a letter , Steve Oldfield, chief commercial officer at the Department of Health and Social Care, said the government is focused on preventing potential disruption to any categories of medical supplies.

111

111

Outsourcing Pharma

AUGUST 3, 2020

Neurasic Therapeutics is borne from a collaborative effort intended to advance development of opioid-alternative pain relief.

96

96

Pharma Times

AUGUST 4, 2020

New deal with Wockhardt boosts capacity at the crucial 'fill and finish' stage

Vaccines 59

Vaccines 59

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

indispensable health

AUGUST 4, 2020

Pre-Interview Tips for Pharmacy Professionals | Tip #1 with Tom Alig | Vice President of Staffing at Indispensable Health Hi, I am Tom Alig, VP of Staffing with Indispensable Health. I’ve been recruiting pharmacists and pharmacy technicians since 2004, and I’ve seen the things good candidates do to separate themselves, and I’ve seen the mistakes that some candidates make.

52

52

pharmaphorum

AUGUST 4, 2020

Shares in Redx Pharma were soaring this morning after it licensed its preclinical fibrotic disease drug RXC006 to AstraZeneca. The company’s shares were valued as high as 95p on the London Stock Exchange following the announcement, the highest they had been since 2015. AstraZeneca has bought an exclusive global licence to develop and market RXC006, a porcupine inhibitor for fibrotic diseases including idiopathic pulmonary fibrosis (IPF).

109

109

Outsourcing Pharma

AUGUST 6, 2020

A leader from the scientific software provider discusses the most challenging obstacles in the pharma supply chain, and solutions that can conquer them.

65

65

Pharma Times

AUGUST 5, 2020

AZ will pay $17m in early milestone payments for the UK biotech’s fibrotic asset

53

53

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

Med Ed 101

AUGUST 5, 2020

While not incredibly common, medications can cause dysregulation of our body’s thermoregulation process and cause a rise in core temperature in the presence of normal core body temperature which leads to hyperthermia. Before we get to the drugs that cause hyperthermia, let’s review thermoregulation. Our body is able to regulate our core temperature to keep […].

40

40

pharmaphorum

AUGUST 7, 2020

Pharma’s reputation has soared due to the COVID-19 pandemic – but coronavirus is starting to bite companies’ sales. Find out more in our roundup of the biggest R&D, market access and digital stories from the past week. The perception of pharma and medical companies has surged upward since the start of the COVID-19 pandemic, but they still lie mostly outside the top-rated firms in the FutureBrand Index.

Nursing Homes 105

Nursing Homes Vaccines Immunization Hospitals 105

Outsourcing Pharma

AUGUST 6, 2020

The agency continues to provide resources for the life-sciences industry, approve tests, and take action against companies offering false treatments.

FDA 60

FDA 60

Pharma Times

AUGUST 5, 2020

Roche, AstraZeneca, Novo Nordisk and Sanofi all climbed index rankings

52

52

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

Med Ed 101

AUGUST 2, 2020

As of August 1st, 2020, pharmacogenomics has been added to the BCMTMS exam content outline. We’ve updated our material to include a review of pharmacogenomic principles and common medications that may be affected by genetic variations. In addition, we’ve added pharmacogenomics quiz questions to our quiz bank. I wanted to share a sample of our […].

40

40

pharmaphorum

AUGUST 4, 2020

Sanofi has been placed under formal investigation in France for possible charges including manslaughter relating to the epilepsy drug Depakine, following the deaths of four babies whose mothers took the drug. Depakine was found to carry a high risk of birth defects if taken by pregnant women. Sanofi , which denies wrongdoing and says it warned of the risks long ago, is already being prosecuted in France following allegations it provided misleading information about the drug.

Communication 105

Communication 105

Outsourcing Pharma

AUGUST 6, 2020

A leader from IBM Watson Health talks about how its advanced EDC solution is geared toward helping studies save precious time and conserve costs.

59

59

Pharma Times

AUGUST 3, 2020

Low-dose and high-dose Cosentyx is effective in rapidly improving skin symptoms and quality of life

52

52

pharmaphorum

AUGUST 5, 2020

The UK digital mental health support platform Kooth has joined with five of the UK’s well known Instagram influencers to launch a campaign to help students deal with the pressures of exam results season. The campaign encourages the hundreds of thousands of students waiting to receive their exam results, to stay mentally strong and know they have access to support, if needed.

105

105

pharmaphorum

AUGUST 6, 2020

Recent months have exacerbated many of the issues that were facing the NHS before anyone had ever heard the word COVID-19 – and the scars are set to remain long after the country gets “back to normal”. In the absence of a vaccine or a reliable SARS-CoV-2 test, the UK could be operating a middle-income country health system with all the expectations and regulatory standards of a high-income one.

Hospitals 97

Hospitals Compounding Vaccines 97

pharmaphorum

AUGUST 6, 2020

The FDA has approved GlaxoSmithKline’s multiple myeloma drug Blenrep, a first-in-class potential blockbuster that will be used in advanced disease. Blenrep (belantamab mafodotin) has been approved in patients who have received at least four therapies including an anti-CD38 such as Darzalex, a proteasome inhibitor and an immunomodulatory agent. This is an accelerated approval based on response data and GSK may need survival data from a larger trial to keep the drug on the market in the longer ter

FDA 87

FDA Adverse Reactions Packaging 87

pharmaphorum

AUGUST 5, 2020

As populations age, multimorbidity becomes an increasingly pertinent issue for healthcare systems. A new action group from the ABPI seeks to bring the NHS, academia and industry together to find new ways to address the problem. The Association’s Dr Sheuli Porkess and Professor Janet Lord from the University of Birmingham tell us more. Multimorbidity is an increasing issue for healthcare and the NHS.

Hospitals 80

Hospitals Labelling 80

pharmaphorum

AUGUST 5, 2020

Bringing clinical trials to patients – rather than the reverse – could be the key to improving recruitment into studies and making them faster, cheaper and more likely to succeed, according to one clinical research organisation (CRO). There’s already plenty of support from regulators for virtual or ‘decentralised’ trials, including from former FDA Commissioner Scott Gottlieb who said last year that the agency was encouraging adoption of this approach to make trials more “agile and efficient”, as

FDA 75

FDA 75

pharmaphorum

AUGUST 5, 2020

The current level of test and trace in the UK is inadequate to prevent a sharp increase in coronavirus infections when schools reopen in September and there is further relaxation of social distancing rules, according to scientists. A second wave of COVID-19 could be avoided if enough people are tested and traced, according to the team from University College London and the London School of Hygiene & Tropical Medicine.

72

72

pharmaphorum

AUGUST 7, 2020

Biogen has bought a licence to co-develop and co-market potential Parkinson’s disease drugs with US biotech Denali, in a deal worth more than $2.1 billion. Denali has been working on small-molecule compounds capable of crossing the blood-brain barrier and Biogen has bought a licence to co-develop and co-market compounds known as LRRK2 inhibitors in Parkinson’s disease.

Compounding 69

Compounding 69

pharmaphorum

AUGUST 7, 2020

Health technology firms Cerner and LRVHealth have invested $6 million in Xealth to scale up its business offering digital health tools to patients and clinicians. The companies said the new relationship aims to give patients control over their own digital data so they can be more engaged in their treatment plans. Cerner and LRVHealth join Xealth’s other investors Atrium Health, Cleveland Clinic, Froedtert and the Medical College of Wisconsin, MemorialCare Innovation Fund, Providence Ventures and

Cerner 59

Cerner 59

Outsourcing Pharma

AUGUST 5, 2020

Representatives from the CDMO offer perspective on problems plaguing the global pharma supply chain, and possible ways to improve them.

59

59

Outsourcing Pharma

AUGUST 5, 2020

Initial information from the life-sciences specialistâs pilot program shows potential pathways to solving common pharma supply chain challenges.

FDA 59

FDA 59

pharmaphorum

AUGUST 5, 2020

The perception of pharma and medical product companies has surged forward since the start of the COVID-19 pandemic, but they still lie mostly outside the top-rated firms in the FutureBrand Index. Roche, AstraZeneca, Novo Nordisk, and Sanofi all shot up the rankings in the first edition of the report since the start of the coronavirus crisis, but the big loser was Gilead Sciences, falling 71 places to 74 in the list since the last edition in 2018.

59

59